DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Luminescence assay are 8

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_3566	Amiodarone	Cardiovascular agents	Anginal and Arrhythmia	Ebola virus	EBOV/Mak	NA	Luminescence assay	Decrease (50 %)	Approved, Investigational	30016444
DrugRepV_3567	Amiodarone	Cardiovascular agents	Anginal and Arrhythmia	Ebola virus	EBOV/Mak	NA	Luminescence assay	Decrease (50 %)	Approved, Investigational	30016444
DrugRepV_3568	Amiodarone	Cardiovascular agents	Anginal and Arrhythmia	Ebola virus	EBOV/Mak	NA	Luminescence assay	Decrease (50 %)	Approved, Investigational	30016444
DrugRepV_3569	Amiodarone	Cardiovascular agents	Anginal and Arrhythmia	Ebola virus	EBOV/May-GPA	NA	Luminescence assay	Decrease (50 %)	Approved, Investigational	30016444
DrugRepV_3570	Amiodarone	Cardiovascular agents	Anginal and Arrhythmia	Ebola virus	EBOV/May-GPA	NA	Luminescence assay	Decrease (50 %)	Approved, Investigational	30016444
DrugRepV_7341	FGIN-1-27	NA	NA	Japanese encephalitis virus	P3		Luminescence assay	Decrease (50 %)	NA	24348901
DrugRepV_7342	Cilnidipine	Cardiovascular agents	Hypertension	Japanese encephalitis virus	P3		Luminescence assay	Decrease (50 %)	Investigational	24348901
DrugRepV_7343	Niclosamide	Antiparasitic products, Insectisides and Repellents	Tapeworm and intestinal fluke infections | Helminthiasis	Japanese encephalitis virus	P3		Luminescence assay	Decrease (50 %)	Approved	24348901